- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Göttingen, Georg-August Universität, Dissertation, 2018
- Schlagwort
-
Peptides
Amyloid
- Ereignis
-
Veröffentlichung
- (wo)
-
Göttingen
- (wer)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (wann)
-
2018
- Urheber
-
Lopez Noguerola, Jose Socrates
- Beteiligte Personen und Organisationen
-
Bayer, Thomas A.
Bayer, Thomas A.
Ehrenreich, Hannelore
Rizzoli, Silvio
Dresbach, Thomas
Outeiro, Tiago Fleming
Jarry, Hubertus
- Handle
-
11858/00-1735-0000-002E-E439-5
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-002E-E439-5-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lopez Noguerola, Jose Socrates
- Bayer, Thomas A.
- Ehrenreich, Hannelore
- Rizzoli, Silvio
- Dresbach, Thomas
- Outeiro, Tiago Fleming
- Jarry, Hubertus
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Entstanden
- 2018
Ähnliche Objekte (12)
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
Prediction of Alzheimer's Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Optimization and characterization of D-peptides for treatment of Alzheimer’s disease
Alzheimer's disease
Microglial Activation in Alzheimer’s Disease
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Dissecting the role of CRH and CRH-R1 in Alzheimer´s disease
The role of TREM2 in pathogenesis and treatment of Alzheimer’s disease
Dissecting the role of CRH and CRH-R1 in Alzheimer´s disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
Prediction of Alzheimer's Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Optimization and characterization of D-peptides for treatment of Alzheimer’s disease
Alzheimer's disease
Microglial Activation in Alzheimer’s Disease
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Dissecting the role of CRH and CRH-R1 in Alzheimer´s disease
The role of TREM2 in pathogenesis and treatment of Alzheimer’s disease
Dissecting the role of CRH and CRH-R1 in Alzheimer´s disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
Prediction of Alzheimer's Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Optimization and characterization of D-peptides for treatment of Alzheimer’s disease
Alzheimer's disease
Microglial Activation in Alzheimer’s Disease
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Dissecting the role of CRH and CRH-R1 in Alzheimer´s disease
The role of TREM2 in pathogenesis and treatment of Alzheimer’s disease